Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00413-6/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc24&_hsenc=p2ANqtz-9PNVU3juCb0llZL26C_3o1Ko03WvT0CSOiLWHukDmCpkpyxAsziy684xXJIRtM5rgKCENHWSUtfziFJV5w1etiPXXl4w&_hsmi=301366357&utm_content=301366357&utm_source=hs_email